Konjen Nipaporn, Napnark Tapakorn, Janchai Siriporn
J Med Assoc Thai. 2015 Jan;98 Suppl 1:S49-56.
To compare the effectiveness ofradial extracorporeal shock wave therapy (rSWET) and ultrasound therapy (US) in the treatment of chronic plantar fasciitis.
Randomized controlled trial.
Department of Rehabilitation Medicine, King Chulalongkorn Memorial Hospital.
Thirty patients who were diagnosed with plantar fasciitis for at least 3 months and who had not responded to other forms of conservative treatment were recruited for this study. They were randomly divided into two groups of 15 patients. The rESWT group was treated with 1 session per week and the US group with 3 sessions per week, with both groups undergoing a total of 6 consecutive weeks of treatment. Visual analog scale (VAS) assessments were performed before and after treatment at 1, 3, 6, 12, and 24 weeks. The mobility subscale of the plantar fasciitis pain and disability scale (PFPS) was measured before and after treatment. Patient satisfaction was evaluated at the conclusion of the 6-week treatment protocol.
VAS pain intensity scores were significantly decreased in both groups (p < 0.001), when measured after treatment at 1, 3, 6, 12, and 24 weeks. The VAS pain scores for the rESWT group dropped significantly more than those of the US group (p < 0.001). At the end of treatment, the PFPS mobility subscale scores in both groups were significantly decreased (p < 0.001). Similar to the VAS pain score outcome, the PFPS mobility subscale score for the rESWT group decreased significantly more than that of the US group (p < 0.001). Patient satisfaction was significantly higher in the rESWT group, relative to the US group (p = 0.025).
In chronic plantar fasciitis treatment, both rESWT and US were found to be effective in reducing pain and increasing mobility; however, statistical analysis showed that rESWT is significantly more effective than US.
比较桡侧体外冲击波疗法（rSWET）和超声疗法（US）治疗慢性足底筋膜炎的效果。
随机对照试验。
朱拉隆功国王纪念医院康复医学科。
招募30例被诊断为足底筋膜炎至少3个月且对其他形式保守治疗无反应的患者进行本研究。他们被随机分为两组，每组15例。rESWT组每周治疗1次，US组每周治疗3次，两组均连续治疗6周。在治疗前以及治疗后1、3、6、12和24周进行视觉模拟量表（VAS）评估。在治疗前后测量足底筋膜炎疼痛与功能障碍量表（PFPS）的活动度子量表。在6周治疗方案结束时评估患者满意度。
在治疗后1、3、6、12和24周测量时，两组的VAS疼痛强度评分均显著降低（p < 0.001）。rESWT组的VAS疼痛评分下降幅度明显大于US组（p < 0.001）。治疗结束时，两组的PFPS活动度子量表评分均显著降低（p < 0.001）。与VAS疼痛评分结果相似，rESWT组的PFPS活动度子量表评分下降幅度明显大于US组（p < 0.001）。相对于US组，rESWT组的患者满意度显著更高（p = 0.025）。
在慢性足底筋膜炎治疗中，rESWT和US均被发现可有效减轻疼痛并提高活动度；然而，统计分析表明rESWT比US显著更有效。
